» Authors » Joseph Broderick

Joseph Broderick

Explore the profile of Joseph Broderick including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 88
Citations 4417
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Brown D, Jeffries J, Broderick J, Trager J, Cheney M, Clemons M, et al.
Mil Med . 2024 Sep; PMID: 39302724
Critical care air transport teams (CCATTs) specialize in providing intensive medical and postoperative resuscitative care during air evacuations. In a 2014 mission, a seasoned CCATT was urgently deployed to evacuate...
2.
Adeoye O, Broderick J, Derdeyn C, Grotta J, Barsan W, Bentho O, et al.
N Engl J Med . 2024 Sep; 391(9):810-820. PMID: 39231343
Background: Intravenous thrombolysis is a standard treatment of acute ischemic stroke. The efficacy and safety of combining intravenous thrombolysis with argatroban (an anticoagulant agent) or eptifibatide (an antiplatelet agent) are...
3.
Stanton R, Aziz Y, Sucharew H, Haverbusch M, Robinson D, Coleman E, et al.
J Am Heart Assoc . 2024 Jun; 13(13):e035102. PMID: 38904225
No abstract available.
4.
Lyden P, Broderick J, Grotta J, Kwiatkowski T, Levine S, Frankel M, et al.
BMC Med Res Methodol . 2023 Nov; 23(1):275. PMID: 37990152
No abstract available.
5.
Albers G, Campbell B, Lansberg M, Broderick J, Butcher K, Froehler M, et al.
Int J Stroke . 2022 Mar; 18(2):237-241. PMID: 35262424
Rationale: While thrombolysis is standard of care for patients with acute ischemic stroke (AIS) within 4.5 h of symptom onset, the benefit of tenecteplase beyond this time window is less...
6.
Ridha M, Aziz Y, Broderick J
Neurol Clin Pract . 2021 Nov; 11(5):e796-e797. PMID: 34840914
No abstract available.
7.
Tanavde V, Broderick J, Windon M, Fakhry C, Matthew Stewart C, Eisele D, et al.
Laryngoscope . 2021 Apr; 131(8):E2461-E2468. PMID: 33797071
Objective(s): Although parotid cancer invading into the temporal bone makes up only a small fraction of all parotid cancers, it is more common and relatively understudied compared with primary cancer...
8.
Mazighi M, Richard S, Lapergue B, Sibon I, Gory B, Berge J, et al.
Lancet Neurol . 2021 Mar; 20(4):265-274. PMID: 33647246
Background: High systolic blood pressure after successful endovascular therapy for acute ischaemic stroke is associated with increased risk of intraparenchymal haemorrhage. However, no randomised controlled trials are available to guide...
9.
Deeds S, Barreto A, Elm J, Derdeyn C, Berry S, Khatri P, et al.
Int J Stroke . 2020 Dec; 16(7):873-880. PMID: 33297893
Background: Intravenous recombinant tissue plasminogen activator is the only proven effective medication for the treatment of acute ischemic stroke. Two approaches that may augment recombinant tissue plasminogen activator thrombolysis and...
10.
Mazighi M, Labreuche J, Richard S, Gory B, Lapergue B, Sibon I, et al.
Front Neurol . 2020 Jul; 11:480. PMID: 32636793
High systolic blood pressure (BP) is associated with an increased risk of intracranial hemorrhage (ICH) in patients undergoing reperfusion therapy. However, there are no data from randomized trials to guide...